Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression. 1990

W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
Heinrich-Pette-institut für Experimentelle Virologie und Immunologie, Universität Hamburg, Federal Republic of Germany.

To further characterize the role of p53 in growing normal Balb/c 3T3 fibroblasts, as well as of p53 in cells of the methylcholanthrene induced fibrosarcoma cell line Meth A, we analysed the effect of inhibition of p53 synthesis by microinjection of p53-specific monoclonal antibody PAb 122 into the nuclei of these cells after release from growth arrest induced by isoleucine starvation (see preceding paper [Steinmeyer et al., this issue] ). We show that microinjection of PAb 122, but not of control immunoglobulins, into the nuclei of both types of cells effectively blocked their re-entry into the S-phase of the cell cycle. Since isoleucine depletion of these cells was shown to lead to a growth arrest at the restriction point (R-point) in the G1-phase of the cell cycle, our results (i) define more precisely the role of p53 in growing cells as a protein controlling transition of the cells through this restriction point, and (ii) demonstrate that mutated p53 in Meth A cells still is functional with regard to cell cycle control at this restriction point. We suggest that p53 acts as a 'gate-keeping' protein at restriction points in the cell cycle, exerting a positive effect on the transition of cells through the cell cycle.

UI MeSH Term Description Entries
D007532 Isoleucine An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of LEUCINE. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels. Alloisoleucine,Isoleucine, L-Isomer,L-Isoleucine,Isoleucine, L Isomer,L-Isomer Isoleucine
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines

Related Publications

W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
November 1990, Oncogene,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
January 1979, Journal of cellular physiology,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
February 1982, Biochemical and biophysical research communications,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
November 1976, Journal of cellular physiology,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
January 1988, Molecular and cellular biology,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
November 1982, Federation proceedings,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
December 1974, Journal of cellular physiology,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
February 2000, Molecular and cellular biology,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
October 1994, Oncogene,
W Deppert, and G Buschhausen-Denker, and T Patschinsky, and K Steinmeyer
January 1997, Cancer investigation,
Copied contents to your clipboard!